MXPA05008489A - Procedimiento de fabricacion para preparaciones liposomicas. - Google Patents

Procedimiento de fabricacion para preparaciones liposomicas.

Info

Publication number
MXPA05008489A
MXPA05008489A MXPA05008489A MXPA05008489A MXPA05008489A MX PA05008489 A MXPA05008489 A MX PA05008489A MX PA05008489 A MXPA05008489 A MX PA05008489A MX PA05008489 A MXPA05008489 A MX PA05008489A MX PA05008489 A MXPA05008489 A MX PA05008489A
Authority
MX
Mexico
Prior art keywords
liposomal
preparation
organic solvent
water
miscible organic
Prior art date
Application number
MXPA05008489A
Other languages
English (en)
Inventor
Ahmad Zafeer
Original Assignee
Neopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharm Inc filed Critical Neopharm Inc
Publication of MXPA05008489A publication Critical patent/MXPA05008489A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

La presente invencion provee procedimientos de fabricacion para preparaciones liposomicas. De conformidad con los metodos, se disuelve una fraccion lipida en un solvente organico miscible en agua. Esta solucion que comprende la fraccion lipida se puede agregar a, y mezclar con una solucion acuosa bajo condiciones para formar una preparacion liposomica a granel. De manera deseable, la preparacion puede incluir uno o mas principios activos. La preparacion liposomica a granel se puede procesar tambien segun se desee, por ejemplo, mediante fraccionamiento o reduccion de tamano, remocion del solvente organico miscible en agua, secado por congelamiento, u otro tratamiento. Los metodos permiten la produccion de formulaciones liposomicas a gran escala o a escala comercial.
MXPA05008489A 2003-02-11 2004-02-11 Procedimiento de fabricacion para preparaciones liposomicas. MXPA05008489A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44689503P 2003-02-11 2003-02-11
PCT/US2004/004555 WO2004071466A2 (en) 2003-02-11 2004-02-11 Manufacturing process for liposomal preparations

Publications (1)

Publication Number Publication Date
MXPA05008489A true MXPA05008489A (es) 2005-10-18

Family

ID=32869567

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05008489A MXPA05008489A (es) 2003-02-11 2004-02-11 Procedimiento de fabricacion para preparaciones liposomicas.

Country Status (9)

Country Link
US (1) US20060034908A1 (es)
EP (1) EP1613284A2 (es)
JP (1) JP2006517594A (es)
KR (1) KR20050105455A (es)
CN (1) CN1753657A (es)
BR (1) BRPI0407415A (es)
EA (1) EA200501285A1 (es)
MX (1) MXPA05008489A (es)
WO (1) WO2004071466A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2584583A1 (en) * 2004-10-28 2006-05-11 Alza Corporation Lyophilized liposome formulations and method
EP1811962A2 (en) * 2004-10-29 2007-08-01 Neopharm, Inc. Manufacturing process for liposomal preparations
US20080121733A1 (en) * 2006-11-29 2008-05-29 Donald Ackley Droplet generating device and method
US7824708B2 (en) * 2006-12-11 2010-11-02 Access Business Group International Llc Liposome containing cardiolipin for improvement of mitochondrial function
EP2146692A1 (en) * 2007-03-19 2010-01-27 Fresenius Kabi Oncology Limited Proliposomal and liposomal compositions
KR20080101056A (ko) * 2007-05-15 2008-11-21 한국화학연구원 지질나노입자를 포함하는 디테르페노이드 알칼로이드계약물 용액 및 이의 제조방법
CN101827613A (zh) 2007-09-27 2010-09-08 免疫疫苗技术有限公司 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
US20100209452A1 (en) * 2007-10-03 2010-08-19 Immunovaccine Technologies, Inc Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
EP2296696B1 (en) 2008-06-05 2014-08-27 ImmunoVaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
US20110250262A1 (en) * 2008-12-24 2011-10-13 Biomedcore, Inc. Method for producing liposome and method for dissolving cholesterol
WO2010118200A2 (en) * 2009-04-08 2010-10-14 Brian Salvatore Liposomal formulations of tocopheryl amides
JP5771366B2 (ja) 2009-09-02 2015-08-26 株式会社バイオメッドコア リポソーム製造装置及び方法
WO2011038068A1 (en) * 2009-09-23 2011-03-31 Formatech, Inc. Methods for the preparation of liposomes
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
EP2813220A3 (en) 2010-04-09 2015-06-17 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
DK2729127T3 (en) * 2011-07-04 2018-08-06 Statens Seruminstitut METHODS FOR LIPOSOMES PREPARATION
CN103181898B (zh) * 2012-11-23 2016-03-09 杭州师范大学 一种奥沙利铂脂质体及其应用
JP2015193580A (ja) * 2014-03-31 2015-11-05 テルモ株式会社 アムホテリシンｂリポソームの製造方法
US9931298B2 (en) 2015-05-26 2018-04-03 Comfort Care For Animals Llc Liposome loading
EP3360577A4 (en) * 2015-10-07 2019-06-12 Ensuiko Sugar Refining Co., Ltd. LIPOSOME COMPRISING A TAXANE COMPOUND
WO2017097196A1 (zh) * 2015-12-08 2017-06-15 正大天晴药业集团股份有限公司 脂质体的制备方法
WO2017097197A1 (zh) * 2015-12-08 2017-06-15 正大天晴药业集团股份有限公司 美西替康的药物组合物
KR20200050982A (ko) 2017-09-04 2020-05-12 이치마루 화루코스 가부시키가이샤 pH 감수성 리포솜 및 그 제조 방법
WO2019191627A1 (en) * 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
CN109925956A (zh) * 2019-04-29 2019-06-25 苏州艾特森制药设备有限公司 一种实验室脂质体制备系统

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665710A (en) * 1990-04-30 1997-09-09 Georgetown University Method of making liposomal oligodeoxynucleotide compositions
AU3922193A (en) * 1992-03-23 1993-10-21 Georgetown University Liposome encapsulated taxol and a method of using the same
JPH08512056A (ja) * 1993-06-30 1996-12-17 ジェネンテク・インコーポレイテッド リポソームの製造法
WO1995024201A1 (fr) * 1994-03-11 1995-09-14 Yoshitomi Pharmaceutical Industries, Ltd. Preparation de liposomes
US6156337A (en) * 1994-07-08 2000-12-05 Opperbas Holding B.V. Method for high loading of vesicles with biopolymeric substances
US6066331A (en) * 1994-07-08 2000-05-23 Barenholz; Yechezkel Method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers
WO1996006112A1 (en) * 1994-08-25 1996-02-29 Instituut Voor Veehouderij En Diergezondheid (Id-Dlo) Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection
WO1997035559A2 (en) * 1996-03-27 1997-10-02 Ortho Pharmaceutical Corporation Manufacture of liposomes and lipid-protein complexes by ethanolic injection and thin film evaporation
US7262173B2 (en) * 1997-03-21 2007-08-28 Georgetown University Chemosensitizing with liposomes containing oligonucleotides
US6126965A (en) * 1997-03-21 2000-10-03 Georgetown University School Of Medicine Liposomes containing oligonucleotides
US20030229040A1 (en) * 1997-03-21 2003-12-11 Georgetown University Cationic liposomal delivery system and therapeutic use thereof
US6559129B1 (en) * 1997-03-21 2003-05-06 Georgetown University Cationic liposomal delivery system and therapeutic use thereof
DE69841002D1 (de) * 1997-05-14 2009-09-03 Univ British Columbia Hochwirksame verkapselung von nukleinsäuren in lipidvesikeln
US6461637B1 (en) * 2000-09-01 2002-10-08 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US6146659A (en) * 1998-07-01 2000-11-14 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US7025988B2 (en) * 2000-02-04 2006-04-11 Lipoxen Technologies Limited Liposomes
WO2001070220A1 (en) * 2000-03-22 2001-09-27 Neopharm, Inc. A method of administering liposomal encapsulated taxane
MXPA03003401A (es) * 2000-10-16 2004-06-30 Neopharm Inc Formulacion liposomica de mitoxantrona.
PL363618A1 (en) * 2000-11-09 2004-11-29 Neopharm, Inc. Sn-38 lipid complexes and methods of use
WO2002059337A1 (en) * 2001-01-26 2002-08-01 Georgetown University School Of Medicine Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof
WO2002081642A2 (en) * 2001-04-06 2002-10-17 Georgetown University Gene brcc-3 and diagnostic and therapeutic uses thereof
WO2002081641A2 (en) * 2001-04-06 2002-10-17 Georgetown University Gene scc-112 and diagnostic and therapeutic uses thereof
AU2002303261A1 (en) * 2001-04-06 2002-10-21 Georgetown University Gene brcc2 and diagnostic and therapeutic uses thereof
WO2003030864A1 (en) * 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
JP2005508375A (ja) * 2001-11-09 2005-03-31 ネオファーム、インコーポレイティッド Ｉｌ−１３を発現する腫瘍の選択的治療
US7244565B2 (en) * 2002-04-10 2007-07-17 Georgetown University Gene shinc-3 and diagnostic and therapeutic uses thereof
US7138512B2 (en) * 2002-04-10 2006-11-21 Georgetown University Gene SHINC-2 and diagnostic and therapeutic uses thereof
US20050148528A1 (en) * 2002-05-20 2005-07-07 Neopharm, Inc Method for reducing platelet count
US20030228317A1 (en) * 2002-05-22 2003-12-11 Prafulla Gokhale Gene BRCC-1 and diagnostic and therapeutic uses thereof
WO2003099830A2 (en) * 2002-05-24 2003-12-04 Neopharm, Inc. Cardiolipin compositions, methods of preparation and use
EA200401565A1 (ru) * 2002-05-24 2005-04-28 Неофарм, Инк. Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
AU2003240934A1 (en) * 2002-05-29 2003-12-19 Neopharm, Inc. Method for determining oligonucleotide concentration
AU2003296897A1 (en) * 2002-08-20 2004-05-04 Neopharm, Inc. Pharmaceutical formulations of camptothecine derivatives
WO2004017944A1 (en) * 2002-08-23 2004-03-04 Neopharm, Inc. Liposomal gemcitabine compositions for better drug delivery
US20050277611A1 (en) * 2002-10-16 2005-12-15 Neopharm, Inc. Cationic cardiolipin analoges and its use thereof

Also Published As

Publication number Publication date
JP2006517594A (ja) 2006-07-27
BRPI0407415A (pt) 2006-01-10
WO2004071466A3 (en) 2004-12-02
CN1753657A (zh) 2006-03-29
EA200501285A1 (ru) 2006-02-24
US20060034908A1 (en) 2006-02-16
EP1613284A2 (en) 2006-01-11
WO2004071466A2 (en) 2004-08-26
KR20050105455A (ko) 2005-11-04

Similar Documents

Publication Publication Date Title
MXPA05008489A (es) Procedimiento de fabricacion para preparaciones liposomicas.
WO2002096457A3 (en) Stable liquid formulations of antibodies
IL174206A0 (en) Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
MXPA05012821A (es) Formulacion farmaceutica que comprende un agente activo insoluble en agua.
CA2369070A1 (en) 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof
HUP0300783A2 (hu) 17alfa-helyen gyűrűs acilcsoporttal észterezett 9 alfa-klór-6alfa-fluor-17alfa-hidroxi-16-metil-17béta-metoxi-karbonil-androszta-1,4-diének, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2002098210A3 (en) Chromosome doubling method
AU5490498A (en) Binder removal
WO2008058547A3 (en) Alpha-lactalbumin composition
WO2000067626A3 (en) Oat extracts: refining, compositions and methods of use
WO2001089571A3 (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
EP2292239A3 (en) Remedies for diseases to be applied to eye
GB2456976A (en) System and process for producing a low suspended solids solution and uses therefore
DE60028152D1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher Komplex von Orthokieselsäure und Prozess zur dessen Herstellung
MX2007005234A (es) Proceso de fabricacion para preparaciones liposomales.
IL153200A0 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING A gOBG3
WO2011076209A3 (en) Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
CA2356959A1 (en) Water-insoluble drug delivery system
WO2005063195A3 (en) Compositions comprising vitamins and/or derivatives thereof stabilised with olea europea extract and/or ionene polymers
DE60118742D1 (de) Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel
ATE428730T1 (de) Verfahren zur herstellung einer alpha-1- antitrypsinlösung
TW200507867A (en) Extract of plant dendrobii caulis and preparing process thereof
IL165807A0 (en) Process for preparing epimerized derivatives of k5polysaccharide with a very high degree of sulfati on and new epi k5-n,o-sulfated polysaccharide derivatives
WO2002018400A3 (en) Methods of preparing disaccharide and trisaccharide c6-c12fatty acid esters with high alpha content and materials therefrom
BR0009636B1 (pt) processo para a preparação de insulina madura ou um derivado de insulina madura.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal